Riamet Baby, Tabletten zur Herstellung einer Suspension zum Einnehmen

7680676640019 CH-67664 Tabletten zur Herstellung einer Suspension zum Einnehmen

No image available

Article details

Package size
12
Selling units
12
Measure
Tablette(n)
Galenic form
Tabletten zur Herstellung einer Suspension zum Einnehmen
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
artemetherum
2.5 MG Substance Wirkstoff (Principe actif)
lumefantrinum
30.0 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
hypromellosum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
crospovidonum
- Substance HNIDK
aromatica
- Substance AROMA
ethylis benzoas
- Substance HBESI
maltodextrinum
- Substance HNIDK
saccharinum natricum
- Substance AIMDK
magnesii stearas
- Substance HNIDK
natrium
0.43 MG Substance HBESI

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
67664
Drug name
Riamet Baby, Tabletten zur Herstellung einer Suspension zum Einnehmen
Galenic form
TABSU
ATC Code
P01BF01
Authorization status
Z
Dispensing category
A
First authorization
03/07/2025
Authorization expiration date
02/07/2030
IT Number
08.04.1.
Domain
Human medicine
Field of application
Behandlung von akuter, unkomplizierter Malaria von Säuglingen mit einem Körpergewicht zwischen 2 kg und unter 5 kg

Package details

Description (FR)
RIAMET Baby cpr disp 2.5 mg 12 pce
Description (DE)
RIAMET Baby Disp Tabl 2.5 mg 12 Stk
Market launch
01/04/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data